Finding the right tests…
Emergency services available 24 x 7
Emergency services available 24 x 7
Finding the right tests…
Molecular
This test uses real-time PCR to count how many copies of hepatitis B virus DNA are in a blood sample, watching the amplification reaction as it happens rather than checking for a result only at the end. That's what lets it report an actual number rather than a simple yes-or-no, and it's the same category of technology used for HIV and hepatitis C viral load testing. Because different real-time PCR assays can vary slightly from each other, comparing results over months of treatment is more reliable when the same assay is used each time. This test is central to deciding whether chronic hepatitis B treatment is working and whether it needs to change.
Results are reported as a viral load number, usually in IU/mL, reflecting how much hepatitis B DNA the real-time PCR reaction detected in your sample. A result that has dropped substantially since your last test, or that has become undetectable, suggests your current treatment is controlling the virus effectively. A result that hasn't moved much, or has risen, suggests the virus isn't being controlled as well as expected, which your doctor may investigate further before deciding whether to adjust your medication. Because assays can vary slightly between labs, results are best compared using the same testing platform over time.
Older PCR methods amplified a sample's DNA fully, then measured the end product once the reaction was already finished. Real-time PCR instead adds a fluorescent marker that lights up as copies are made, so the machine tracks the reaction as it's actually happening and calculates the starting amount of viral DNA from how quickly the signal builds.
Because the signal grows in step with how much virus was there to begin with, real-time PCR can report a specific viral load rather than just detecting presence or absence. This is the same underlying technology used to monitor HIV and hepatitis C viral loads, adapted here to track hepatitis B DNA specifically.
Different real-time PCR assays can be calibrated slightly differently, even when both report results in IU/mL, which is why doctors generally prefer to track a person's viral load using the same assay or the same lab across repeat tests during treatment. Switching platforms partway through monitoring can make a genuine change in viral load harder to interpret confidently.
For someone already on antiviral treatment, this test is usually repeated at intervals your doctor sets, since a viral load that keeps falling is reassuring, while one that plateaus or rises again can be an early sign that the current medication needs a closer look.
It means the machine tracks the PCR reaction as it happens, using a fluorescent signal, instead of only checking the result once the reaction is finished. That's what allows the test to report an actual viral load number rather than a simple positive or negative.
Because this test measures how much hepatitis B virus DNA is in your blood, not just whether it's present. Tracking that number over time is what shows your doctor whether treatment is working.
It's generally a good idea. Different real-time PCR assays can be calibrated slightly differently, so comparing results from the same lab or platform over time gives a more reliable picture of whether your viral load is truly changing.
This page is general information about the test, not medical advice. Your own report's reference ranges apply — please discuss your results with your doctor.
It can suggest the virus isn't being controlled as well as expected, which might relate to how consistently the medication is being taken or, less commonly, developing resistance. Your doctor will look into this before deciding whether to adjust treatment.
Mainly yes. It's used in people with a confirmed hepatitis B infection to guide treatment decisions and monitor response, rather than as a first screening test.
The surface antigen test tells your doctor whether you have an active infection. This test goes further and measures how much virus is actively replicating, which is what treatment decisions and monitoring depend on.